KAREN BEAN: Open Payments
NPI 1326132432 · CALDWELL, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 9 payments from 5 companies in 2025. Trend: 2023 $149 · 2024 $116 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Amgen Inc. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $16 |
Products named: FARXIGA, Wegovy, GVOKE HYPOPEN, Ozempic, Korlym, OTEZLA, EVENITY.
Industry payments across ID — which companies pay providers there.
